1st Quarter - Report

CAPITOL HILL CONSULTING GROUP for NOVARTIS CORPORATION

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General healthcare issues related to vaccine and prescription drug legislation; comparative effectiveness research; Public Health Service Act; drug importation; (S.1505) Affordable Biologics for Consumers Act; (S.1695) Biologics Price Competition and Innovation Act; (H.R. 1956) Patient Protection and Innovative Biologic Medicines Act; (H.R. 1038) Access to Life-Saving Medicine Act; (S.623) Access to Life Saving Medicine Act; direct to consumer advertising; FDA funding; Reagan/Udall Foundat

LobbyistCovered position, as disclosed
BILL K BREWSTER —
WILLIAM DUNCAN —
STEVEN E IRIZARRY —
DAVID JORY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1505 (110th), H.R. 1956 (110th), H.R. 1038 (110th), S. 1695 (110th), S. 623 (110th)

Budget/Appropriations BUD

DoD Authorization Language- Section 701, Dealing with TriCare; FY2009 Labor HHS Appropriations Bill; FY2009 Department of Defence Appropriations Bill; 2009 Supplemental Appropriations Bill

LobbyistCovered position, as disclosed
BILL K BREWSTER —
WILLIAM DUNCAN —
STEVEN E IRIZARRY —
DAVID JORY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

(S. 2029) Physician Payments Sunshine Act; Access to Life Saving Medicines Act; Medicare Part D-Non-Interference; Medicare Prescription Drugs and Modernization Act; (H.R. 3023) Drug and Medical Device Company Gift Disclosure Act; (S. 2041) False Claims Act Correction Act; (HR 4854) False Claims Act Correction Act;( HR 3610) Food and Drug Import Safety Act

LobbyistCovered position, as disclosed
BILL K BREWSTER —
WILLIAM DUNCAN —
STEVEN E IRIZARRY —
DAVID JORY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4854 (110th), S. 2029 (110th), S. 2041 (110th), H.R. 3610 (110th), H.R. 3023 (110th)

Pharmacy PHA

Pharmaceutical and life sciences issues, including but not limited to: The Federal Food, Drug and Cosmetic Act; the Hatch-Waxman Act; drug safety

LobbyistCovered position, as disclosed
BILL K BREWSTER —
WILLIAM DUNCAN —
STEVEN E IRIZARRY —
DAVID JORY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

General tax issues

LobbyistCovered position, as disclosed
BILL K BREWSTER —
WILLIAM DUNCAN —
STEVEN E IRIZARRY —
DAVID JORY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Government Issues GOV

general patent issues

LobbyistCovered position, as disclosed
BILL K BREWSTER —
WILLIAM DUNCAN —
STEVEN E IRIZARRY —
DAVID JORY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.